Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MINIMUM EFFECTIVE AND MAXIMUM DIAPHRAGM-SPARING VOLUME OF BUPIVACAİNE FOR ULTRASOUND GUIDED ANTERIOR SUPRASCAPULAR NERVE BLOCK

NCT05241977 is registered in ClinicalTrials.gov with V.K.V. American Hospital, Istanbul as lead sponsor.

NCT NCT05241977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05241977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MINIMUM EFFECTIVE AND MAXIMUM DIAPHRAGM-SPARING VOLUME OF BUPIVACAİNE FOR ULTRASOUND GUIDED ANTERIOR SUPRASCAPULAR NERVE BLOCK
Lead sponsor
V.K.V. American Hospital, Istanbul
Phase
Observational
Overall status
Completed
Start date
March 7, 2022
Completion date
July 13, 2022
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bankart lesions, shoulder pain, supraspinatus tendinitis